Pricing

Eliem Therapeutics Inc (ELYM)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Robert W. Azelby
Employees:
20
2801 CENTERVILLE ROAD 1ST FLOOR, PMB #117, WILMINGTON, DE, 19808
877-354-3689
Eliem Therapeutics, Inc. focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. The company also develops preclinical pipeline programs, such as Kv7 Program for pain, epilepsy and depression.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available